MedTrace Logo

To Calculate the Pharmacokinetics (Concentration of Compound in and Rate of Excretion From the Blood) Following a Very Low Dose of Compound Which Will Not Have Any Pharmacological Activity

NCT01165736 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2010-08-24

No results posted yet for this study

Summary

The purpose of this study is to calculate the pharmacokinetics (concentration of compound in and rate of excretion from the blood) following a very low dose of compound which will not have any pharmacological activity and to monitor for the safety and tolerability of each of the compounds in the study.

Conditions

  • Healthy

Interventions

DRUG

PF-05186462

single intravenous infusion of 100 microgram

DRUG

PF-05186462

single oral administration of 100 microgram

DRUG

PF-05089771

single intravenous infusion of 100 microgram of PF-05089771

DRUG

PF-05089771

single oral administration of 100 microgram PF-05089771

DRUG

PF-05150122

single intravenous administration of 100 microgram PF-05150122

DRUG

PF-05150122

single oral administration of 100 microgram PF-05150122

DRUG

PF-05241328

single intravenous infusion of 100 microgram PF-05241328

DRUG

PF-05241328

single oral administration 100 microgram PF-05241328

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01165736 on ClinicalTrials.gov